ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

American Cancer Society Elects Officers, Distributes Awards

November 24, 1995

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

Scientists Glimpse Cellular Machines Inside Living Cells; Funding Opportunities

November 22, 2002

In Brief: M.D. Anderson Selects Raphael Pollock To Lead Surgery Div.; S.F. VA Picks Norton

September 12, 1997

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995